Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Wave VI Feasibility Study: Phase II Randomized Sham Controlled Study of Renal Denervation for Untreated Stage I and II Hypertension

NCT02480517 is registered in ClinicalTrials.gov with Kona Medical Inc. as lead sponsor.

NCT NCT02480517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02480517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Wave VI Feasibility Study: Phase II Randomized Sham Controlled Study of Renal Denervation for Untreated Stage I and II Hypertension
Lead sponsor
Kona Medical Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2016
Completion date
December 31, 2017
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension